Pennant Group Overview
Pennant Group (PNTG) has a P/E ratio of 41.36, above the Healthcare sector average of 26.85.
Get informed when a big investor buys or sells
+ Follow41.36
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for PNTG is 41.36. That is above the Healthcare sector average of 26.85. Investors often review this figure alongside Pennant Group's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, PNTG currently prints 41.36 for P/E ratio, while the sector average sits near 26.85. That is roughly 54.1% above the sector mean. Large gaps often invite a closer look at Pennant Group's growth, margins, and balance sheet.
A P/E ratio of 41.36 for Pennant Group is not 'good' or 'bad' on its own. Compare it with the peer average (26.85) and with PNTG's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting PNTG's P/E ratio (41.36), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Pennant Group's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
